Cargando…

COF-based artificial probiotic for modulation of gut microbiota and immune microenvironment in inflammatory bowel disease

Conventional strategies for treating inflammatory bowel disease merely relieve inflammation and excessive immune response, but fail to solve the underlying causes of IBD, such as disrupted gut microbiota and intestinal barrier. Recently, natural probiotics have shown tremendous potential for the tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Qingqing, Zhang, Lu, Liu, Xuemeng, Kang, Lihua, Yi, Jiadai, Ren, Jinsong, Qu, Xiaogang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2022
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906670/ https://www.ncbi.nlm.nih.gov/pubmed/36794177 http://dx.doi.org/10.1039/d2sc04984h

Ejemplares similares

Irritable Bowel Syndrome, Gut Microbiota and Probiotics
por: Lee, Beom Jae, et al.
Publicado: (2011)

Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
por: Li, Lingfeng, et al.
Publicado: (2022)

The Use of Probiotic Therapy to Modulate the Gut Microbiota and Dendritic Cell Responses in Inflammatory Bowel Diseases
por: Alagón Fernández del Campo, Pablo, et al.
Publicado: (2019)

Molecular insight into COF monolayers for urea sorption in artificial kidneys
por: Jahromi, Ahmad Miri, et al.
Publicado: (2021)

Gut Microbiota in Inflammatory Bowel Disease
por: Shim, Jung Ok
Publicado: (2013)

The gut microbiota and inflammatory bowel disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2014)

The Gut Microbiota in Inflammatory Bowel Disease
por: Qiu, Peng, et al.
Publicado: (2022)

Inflammatory Bowel Diseases and Gut Microbiota
por: Haneishi, Yuri, et al.
Publicado: (2023)

Association between intestinal microbiota and inflammatory bowel disease
por: Zhang, Yunchang, et al.
Publicado: (2022)

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery
por: Zhou, Jun, et al.
Publicado: (2022)

A Proresolving Peptide Nanotherapy for Site‐Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota
por: Li, Chenwen, et al.
Publicado: (2019)

The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases
por: Zou, Fei, et al.
Publicado: (2023)

High-Throughput Screening of COF Membranes and COF/Polymer MMMs for Helium Separation and Hydrogen Purification
por: Aydin, Sena, et al.
Publicado: (2022)

Gut microbiota, probiotics and diabetes
por: Gomes, Aline Corado, et al.
Publicado: (2014)

Identification of Two Metallothioneins as Novel Inhalative Coffee Allergens Cof a 2 and Cof a 3
por: Peters, Ulrike, et al.
Publicado: (2015)

Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease
por: Hu, Yongjia, et al.
Publicado: (2022)

The gut microbiota in mouse models of inflammatory bowel disease
por: Gkouskou, Kalliopi K., et al.
Publicado: (2014)

The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
por: Zuo, Tao, et al.
Publicado: (2018)

Diet and microbiota in inflammatory bowel disease: The gut in disharmony
por: Rapozo, Davy C M, et al.
Publicado: (2017)

Gut microbiota, inflammatory bowel disease and colorectal cancer
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2022)

Gut Microbiota, Probiotics, and Human Health
por: SUVOROV, Alexander
Publicado: (2013)

The Gut Microbiota in Celiac Disease and Probiotics
por: Chibbar, Richa, et al.
Publicado: (2019)

Cellular Stress Responses and Gut Microbiota in Inflammatory Bowel Disease
por: Cao, Siyan “Stewart”
Publicado: (2018)

Gut Microbiota-driven Drug Metabolism in Inflammatory Bowel Disease
por: Crouwel, Femke, et al.
Publicado: (2020)

The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
por: Baldelli, Valerio, et al.
Publicado: (2021)

Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease
por: Sultan, Salma, et al.
Publicado: (2021)

Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease
por: Guo, Xue, et al.
Publicado: (2022)

Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease
por: Pavel, Flavia Maria, et al.
Publicado: (2021)

Gut microbiota and inflammatory bowel disease: The current status and perspectives
por: Zheng, Lie, et al.
Publicado: (2021)

Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases
por: Candelli, Marcello, et al.
Publicado: (2021)

The Nexus of Diet, Gut Microbiota and Inflammatory Bowel Diseases in Dogs
por: Rhimi, Soufien, et al.
Publicado: (2022)

Dynamic Population of Gut Microbiota as an Indicator of Inflammatory Bowel Disease
por: Salimi, Afsaneh, et al.
Publicado: (2022)

Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update
por: Tan, Pufang, et al.
Publicado: (2020)

Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review
por: Zhuang, Xiaojun, et al.
Publicado: (2021)

Not all Probiotics are the Same: Gut Microbiota Modulation with a Multistrain Probiotics
por: Betta, Pasqua
Publicado: (2014)

Role of metabolites derived from gut microbiota in inflammatory bowel disease
por: Zheng, Lie, et al.
Publicado: (2022)

Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission
por: Pisani, Anthea, et al.
Publicado: (2022)

Evidence challenging the causal role of gut microbiota in inflammatory bowel diseases
por: Jiao, Na, et al.
Publicado: (2023)

Special Issue “Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets”
por: Filidou, Eirini, et al.
Publicado: (2023)

How Early-Life Gut Microbiota Alteration Sets Trajectories for Health and Inflammatory Bowel Disease?
por: Guo, Feilong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u70spdm3b7qse1s4kb4edmmmsg